Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	596,980	274,001	162,977	69,260	94,374	47,636
Market Cap Growth	59.36%	68.12%	135.31%	-26.61%	98.11%	-
Enterprise Value	544,283	246,568	173,751	74,437	81,942	-
Last Close Price	12270.00	5610.00	3115.15	1295.47	1935.68	977.06
PE Ratio	9.23	4.42	5.52	3.33	5.76	4.22
PS Ratio	0.68	0.33	0.29	0.17	0.30	0.16
PB Ratio	3.78	1.86	1.69	0.94	2.28	1.90
P/TBV Ratio	3.91	1.94	1.74	0.97	2.36	2.00
P/FCF Ratio	7.43	3.68	19.79	-	-	6.71
P/OCF Ratio	7.31	3.62	18.74	-	-	6.22
EV/Sales Ratio	0.62	0.30	0.31	0.19	0.26	-
EV/EBITDA Ratio	5.29	2.47	2.95	1.93	2.74	-
EV/EBIT Ratio	6.12	2.86	3.73	2.71	3.88	-
EV/FCF Ratio	6.78	3.31	21.09	-	-	-
Debt / Equity Ratio	0.34	0.40	0.66	0.39	0.67	0.91
Debt / EBITDA Ratio	0.53	0.58	1.09	0.75	0.93	1.01
Debt / FCF Ratio	0.68	0.78	7.76	-	-	3.20
Asset Turnover	1.30	1.38	1.41	1.58	1.61	-
Quick Ratio	0.41	0.40	0.36	0.35	0.35	0.48
Current Ratio	1.16	1.18	1.29	1.23	1.13	1.10
Return on Equity (ROE)	49.96%	50.84%	34.68%	36.19%	49.26%	-
Return on Assets (ROA)	8.25%	8.95%	7.38%	6.78%	6.77%	-
Return on Capital (ROIC)	29.37%	29.45%	22.15%	20.06%	22.59%	-
Return on Capital Employed (ROCE)	41.70%	41.20%	28.40%	30.30%	39.80%	47.20%
Earnings Yield	10.91%	22.64%	18.11%	30.01%	17.37%	23.70%
FCF Yield	13.45%	27.16%	5.05%	-2.48%	-1.94%	14.90%
Dividend Yield	0.81%	1.78%	2.25%	4.63%	-	-
Payout Ratio	5.41%	5.68%	10.45%	-	-	-
Buyback Yield / Dilution	3.80%	4.00%	-1.24%	-12.72%	-	-
Total Shareholder Return	4.65%	5.78%	1.00%	-8.09%	-	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.